George Medicines

George Medicines is a late-stage biopharmaceutical company addressing significant unmet need in the treatment of cardiometabolic diseases.

[George Medicines @GeorgeMedicines]

In our latest Q&A, Gary Quashie, our Senior Director, Business Development, Licensing & Alliance Management, shares what drew him to #GeorgeMedicines, his guiding philosophy and where BD is headed next.

Learn more: https://t.co/ZaabN4KIqV

#BD

[George Medicines @GeorgeMedicines]

Congratulations to Dr. Tian Wang on winning the Young Investigator Award in Preventative Cardiology at ESC 2026.
#ESCCongress2026 #CardiometabolicHealth #Hypertension

[George Medicines @GeorgeMedicines]

New TRIDENT data presented today at #ESC2026 by The George Institute for Global Health’s Dr Anthony Rodgers and Dr Tian Wang who shared findings on #bloodPressure variability. Abstracts on the ESC website https://t.co/XMYourVMTH #GeorgeMedicines #ESCCongress2026

[George Medicines @GeorgeMedicines]

Pleased to share that Mark Mallon (CEO), Anthony Rodgers (CMO) and Amy Carroll (SVP Medical Affairs) will attend @escardio Congress 2026 in Munich from 28-31 August.

Reach out if you'll be there too!

#GeorgeMedicines #ESCCongress #ESC2026

[George Medicines @GeorgeMedicines]

Data on GMRx2 have been selected for presentation at the @esccardio (ESC) Congress 2026 in Munich, 28-31 August.

Full details here: https://t.co/WJbM0Iv4gb

#ESCCongress2026

[George Medicines @GeorgeMedicines]

Important findings from a major meta-analysis have been published in @TheLancetNeuro showing the importance of long-term #bloodPressure control as a cornerstone of reduction of risk of recurrent #stroke.
Learn more: https://t.co/nal0B9YCp6

#Hypertension #CardiovascularHealth

[George Medicines @GeorgeMedicines]

We are excited to welcome Brendan Walsh as our new SVP of Supply Chain & Technical Operations! With 20 years of global pharma supply chain experience, Brendan joins at a pivotal moment as we expand our #GMRx2 franchise worldwide. Welcome, Brendan! https://t.co/xbTrPTCRHh #Biotech

[George Medicines @GeorgeMedicines]

Join the @WorldStrokeOrg & WHL webinar on #bloodPressure management in #intracerebralHemorrhage, sponsored by #GeorgeMedicines, tomorrow at 2pm CEST. Register: https://t.co/PXE8Cua0tB #StrokeCare #Hypertension #ICH

[George Medicines @GeorgeMedicines]

Please join this expert-led @WorldStrokeOrg & WHL webinar on June 24, 2pm CEST on the role of #bloodPressure management across the ICH care continuum, from hyperacute treatment to long‑term prevention. Register: https://t.co/0hZuqFhN68 Sponsored by George Medicines

[George Medicines @GeorgeMedicines]

Our SVP of Medical Affairs Amy Carroll has just returned from the @ESHypertension Congress 2026 in Gdańsk, Poland.

Her key takeaway: the future of hypertension management will be defined by our ability to implement proven strategies at scale.

#ESH2026 #GeorgeMedicines

[George Medicines @GeorgeMedicines]

Today is #WorldHypertensionDay. Over 1bn people have hypertension, yet fewer than 1 in 5 have it under control. Our mission is to extend and improve the lives of the millions of people suffering from #cardiometabolic diseases, including #hypertension. #WHD2026

[George Medicines @GeorgeMedicines]

To mark #StrokeAwarenessMonth, we spoke with Pamela Kushner, MD, Clinical Professor University of California at Irvine, on the evolving landscape of stroke prevention and care.

Read more: https://t.co/s29knQoJUa

#GeorgeMedicines #StrokePrevention #hypertension #GlobalHealth

[George Medicines @GeorgeMedicines]

This month is May Measurement Month. Over 10 million lives are lost every year due to #highBloodPressure, yet only 50% of people affected even know they have it.

Join the cause this May: https://t.co/GjG8tcLOko

#MMM2026 #GeorgeMedicines

[George Medicines @GeorgeMedicines]

In this week’s @NEJM – TRIDENT, the global stroke outcomes trial that demonstrated reduction of risk for recurrent #stroke by almost 40% with #GMRx2 in patients with previous intracerebral hemorrhage. Learn more https://t.co/1ONqcdL5AY #NEJM #Hypertension #CardiovascularHealth